CENPIP1: A Potential Drug Target and Biomarker (G100419337)

Target Name: CENPIP1

NCBI ID: G100419337

CENPIP1

Other Name(s): centromere protein I pseudogene 1 | Centromere protein I pseudogene 1

CENPIP1: A Potential Drug Target and Biomarker

CENPIP1, also known as centromere-associated protein 1, is a protein that is expressed in a variety of tissues throughout the body. It is a key component of the centromere region of chromosomes, which plays a critical role in the proper formation of chromosomes during cell division. CENPIP1 has been identified as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The discovery of CENPIP1 as a potential drug target stems from its unique structure and location on the chromosome. CENPIP1 is composed of 154 amino acid residues and has a calculated molecular mass of 19.9 kDa. It is located at the center of the centromere region on chromosome 16, which is a gene cluster that is highly conserved across various species.

CENPIP1's unique location on the chromosome and its role in the formation of chromosomes make it an attractive target for drugs that can disrupt its function. Studies have shown that inhibiting CENPIP1 can lead to the disruption of chromosomal stability, which can have a range of negative consequences for the cell, including the development of chromosomal abnormalities and the risk of cancer.

In addition to its potential as a drug target, CENPIP1 has also been identified as a potential biomarker for a variety of diseases. Its expression has been observed in a variety of tissues and has been associated with the development of a range of diseases, including neurodegenerative disorders, cancer, and autoimmune disorders.

One of the key challenges in studying CENPIP1 as a potential biomarker is its limited expression in certain tissues. While it is expressed in many tissues, it is not expressed in certain tissues, such as muscle and heart tissue, which makes it difficult to study its effects in these tissues. Additionally, CENPIP1 is a large protein with a complex structure, which can make it difficult to study its interactions with other proteins.

Despite these challenges, research into CENPIP1 as a potential biomarker is ongoing. Researchers are working to develop methods for its detection and study in different tissues, as well as to understand its potential interactions with other proteins. The goal is to use CENPIP1 as a diagnostic tool and to develop drugs that can target its function to treat a variety of diseases.

In addition to its potential as a drug target and biomarker, CENPIP1 has also been identified as a potential therapeutic target for a variety of diseases. Its unique structure and location on the chromosome make it an attractive target for drugs that can disrupt its function. Studies have shown that inhibiting CENPIP1 can lead to the disruption of chromosomal stability and the development of a range of cellular and tissue abnormalities. This suggests that CENPIP1 may be a useful target for drugs that are designed to disrupt the structure and function of cancer cells.

Overall, the discovery of CENPIP1 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. Further research is needed to fully understand its function and to develop drugs that can target its unique structure and location on the chromosome.

Protein Name: Centromere Protein I Pseudogene 1

The "CENPIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CENPIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets